Table 5.
Patient and Tumor Specific Characteristics by Breast Surgeon
| Surgeon 1 | Surgeon 2 | Surgeon 3 | Surgeon 4 | Surgeon 5 | Surgeon 6 | Surgeon 7 | Surgeon 8 | Surgeon 9 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Age | ||||||||||
| < 40 | 29 (6.6%) | 15 (5.2%) | 5 (4.0%) | 7 (2.3%) | 28 (7.4%) | 7 (8.1%) | 15 (4.8%) | 12 (4.6%) | 23 (7.6%) | |
| 40–49 | 118 (26.8%) | 52 (18.1%) | 38 (30.7%) | 68 (23.0%) | 86 (22.7%) | 18 (20.7%) | 77 (24.4%) | 59 (22.8%) | 87 (28.9%) | |
| 50–59 | 113 (25.6%) | 78 (27.2%) | 33 (26.6%) | 65 (22.0%) | 116 (30.6%) | 23 (26.4%) | 79 (25.1%) | 65 (25.1%) | 74 (24.6%) | |
| 60–69 | 116 (26.3%) | 74 (25.8%) | 30 (24.2%) | 88 (29.7%) | 104 (27.4%) | 25 (28.7%) | 83 (26.3%) | 75 (29.0%) | 74 (24.6%) | |
| 70 + | 65 (14.7%) | 68 (23.7%) | 18 (14.5%) | 68 (23.0%) | 45 (11.9%) | 14 (16.1%) | 61 (19.4%) | 48 (18.5%) | 43 (14.3%) | |
| Race | ||||||||||
| White | 390 (88.4%) | 237 (82.6%) | 106 (85.5%) | 260 (87.8%) | 348 (91.8%) | 61 (70.1%) | 218 (69.2%) | 206 (79.5%) | 259 (86.0%) | |
| Non-White | 42 (9.5%) | 34 (11.8%) | 16 (12.9%) | 25 (8.5%) | 26 (6.9%) | 10 (11.5%) | 67 (21.3%) | 31 (12.0%) | 33 (11.0%) | |
| Missing | 9 (2.1%) | 16 (5.6%) | 2 (1.6%) | 11 (3.7%) | 5 (1.3%) | 16 (18.4%) | 30 (9.5%) | 22 (8.5%) | 9 (3.0%) | |
| Language | ||||||||||
| English | 433 (98.2%) | 273 (95.1%) | 115 (92.7%) | 288 (97.3%) | 375 (98.2%) | 85 (97.7%) | 291 (92.4%) | 245 (94.6%) | 289 (96.0%) | |
| Non-English | 8 (1.8%) | 14 (4.9%) | 9 (7.3%) | 8 (2.7%) | 7 (1.8%) | 2 (2.3%) | 24 (7.6%) | 14 (5.4%) | 12 (4.0%) | |
| Insurance | ||||||||||
| Private | 296 (67.1%) | 192 (66.9%) | 90 (72.6%) | 179 (60.5%) | 275 (72.6%) | 62 (71.3%) | 207 (65.7%) | 160 (61.8%) | 215 (71.4%) | |
| Medicaid | 8 (1.8%) | 10 (3.5%) | 3 (2.4%) | 6 (2.0%) | 3 (0.8%) | 4 (4.6%) | 10 (3.2%) | 13 (5.0%) | 14 (4.7%) | |
| Medicare | 121 (27.5%) | 82 (28.6%) | 30 (24.2%) | 107 (36.2%) | 100 (26.4%) | 20 (23.0%) | 97 (30.8%) | 83 (32.0%) | 69 (22.9%) | |
| Other | 16 (3.6%) | 3 (1.0%) | 1 (0.8%) | 4 (1.3%) | 1 (0.2%) | 1 (1.1%) | 1 (0.3%) | 3 (1.2%) | 3 (1.0%) | |
| Stage* | ||||||||||
| 0 | 31 (9.3%) | 12 (7.0%) | 5 (6.9%) | 11 (6.6%) | 31 (12.0%) | 4 (6.7%) | 15 (6.4%) | 19 (8.8%) | 17 (8.7%) | |
| 1 | 205 (61.8%) | 109 (63.7%) | 36 (49.3%) | 92 (55.1%) | 142 (55.0%) | 28 (46.7%) | 147 (63.1%) | 130 (60.5%) | 101 (51.5%) | |
| 2 | 79 (23.8%) | 35 (20.5%) | 27 (37.0%) | 53 (31.7%) | 71 (27.5%) | 20 (33.3%) | 57 (24.5%) | 50 (23.2%) | 60 (30.6%) | |
| 3 | 16 (4.8%) | 14 (8.2%) | 5 (6.8%) | 11 (6.6%) | 13 (5.1%) | 7 (11.7%) | 12 (5.1%) | 15 (7.0%) | 16 (8.2%) | |
| 4 | 1 (0.3%) | 1 (0.6%) | 0 | 0 | 1 (0.4%) | 1 (1.6%) | 2 (0.9%) | 1 (0.5%) | 2 (1.0%) | |
| Surgery Type | ||||||||||
| Lumpectomy | 259 (58.7%) | 208 (72.5%) | 59 (47.6%) | 185 (62.5%) | 269 (71.0%) | 42 (48.3%) | 208 (66.0%) | 169 (65.2%) | 174 (57.8%) | |
| Mastectomy | 54 (12.3%) | 32 (11.1%) | 30 (24.2%) | 41 (13.8%) | 44 (11.6%) | 17 (19.5%) | 42 (13.4%) | 46 (17.8%) | 50 (16.6%) | |
| Mastectomy with Recon | 128 (29.0%) | 47 (16.4%) | 35 (28.2%) | 70 (23.6%) | 66 (17.4%) | 28 (32.2%) | 65 (20.6%) | 44 (17.0%) | 77 (25.6%) | |
*
Tumor Stage was not available for all patients in the cohort